All Substitutes
Loading...
Disclaimer
Did you find this information helpful?




Soliqua Solostar Injection
Prescription Required
Salt Composition : Insulin Glargine,lixisenatide
Manufacturer : SANOFI INDIA LTD
Origin of Medicine : Germany
1 Preflled Pen Device(s)
Introduction to Soliqua Solostar Injection
Soliqua Solostar Injection contains the active ingredients of Insulin glargine and Lixisenatide which belong to the class of Long-Acting Insulins and Glucagon-like Peptide-1 agonists, respectively. It is used to control blood sugar levels and elevate the production of insulin in the body. It also helps to slow down glucose absorption from foods.
It aids in treating type 2 diabetes in adults and controls blood sugar when it becomes abnormal. If other medicines fail to treat or control high blood glucose levels, Soliqua Solostar Injection can be given along with metformin and/or sodium-glucose co-transporter-2 (SGLT2) inhibitors. Inform your doctor if you're allergic to Insulin glargine, Lixisenatide, or any of the ingredients present in the medicine.
Consult your healthcare provider if you have type 1 diabetes mellitus, diabetic ketoacidosis, heart problems, pancreatitis, and stomach or gut problems. Inform your doctor if you have a severe kidney disorder or are under dialysis treatment. It is recommended to speak with your doctor and monitor your blood sugar level before using the medicine. Inform your doctor if you are an elderly patient or have a kidney or liver problem, which will help them to adjust the dose accordingly. The safety and efficacy of the medicine in children and adolescents under 18 years of age have not been established.
Uses of Soliqua Solostar Injection
- Type 2 diabetes
Therapeutic Effects of Soliqua Solostar Injection
The Insulin glargine in the medicine, helps to lower the blood glucose level by replacing the insulin which is normally produced in our body. The Lixisenatide is an GLP-1 agonist, which stimulates the release of insulin during the hyperglycemia (high blood glucose level).
Interaction of Soliqua Solostar Injection with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Soliqua Solostar Injection and can cause undesirable side effects.
More Information about Soliqua Solostar Injection
- Store at 2°C - 8°C
- Keep children away from the sight and reach of this medication.
How to consume Soliqua Solostar Injection
The medicine will be administered to you by a healthcare professional. It is usually administered in the skin (subcutaneously). Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.
Safety Advices for Soliqua Solostar Injection
Pregnancy
It is unknown whether Soliqua Solostar Injection is harmful to the unborn baby. Notify your healthcare professional if you are pregnant or planning to have a baby or think you might be pregnant.
Breast Feeding
It is unknown whether Soliqua Solostar Injection is excreted in breast milk. So, before starting the treatment, inform your doctor if you are breastfeeding. Consult your doctor for more information.
Lungs
It is unknown whether Soliqua Solostar Injection is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Liver
Inform your physician about any underlying liver disorders before taking Soliqua Solostar Injection, as this medication needs a dosage adjustment for liver patients.
Alcohol
Inform your doctor if you have a history of alcoholism before using the medicine. Drinking alcohol during the treatment can either raise or lower your blood sugar level.
Driving
Soliqua Solostar Injection may cause side effects like dizziness or you may have a risk of low blood sugar level which can affect the ability of driving. It is recommended to speak with your doctor for further details.
Side Effects of Soliqua Solostar Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Low blood sugar (hypoglycemia)
Common
- Dizziness
- Feeling sick
- Vomiting
- Injection site reaction
- Headache
- Diarrhea
- Respiratory tract infection (cold or sore throat)
Word of Advice
Drinking enough water is recommended to compensate for the water loss during diarrhea or vomiting. Following a diet with less sugar and regular exercise can help you improve the treatment output and manage diabetes. It is recommended to speak with your doctor about your diabetes symptoms to get an appropriate treatment for your diabetic type.
FAQs
Q 1. Can I take Soliqua Solostar Injection for type 1 diabetes?
No, Insulin glargine and lixisenatide are intended to treat type 2 diabetes in patients, Whereas type 1 diabetes is an autoimmune disorder which any other treatment option cannot cure.
Q 2. Can I experience low blood levels while taking Soliqua Solostar Injection?
Yes, you may experience low blood glucose levels while using the medicine. It is advised to monitor your blood glucose level during the treatment to avoid complications caused by hyperglycemia (low blood glucose level).
Q 3. Is Soliqua Solostar Injection safe to use for liver patients?
Inform your doctor if you have a liver problem, which will help them to adjust the dose accordingly.
Fact Box of Soliqua Solostar Injection
Molecule name: Insulin glargine, Lixisenatide | Therapeutic class: Anti-diabetic |
Pharmacological class: 1. Insulin analogue 2. Glucagon-like peptide-1 (GLP-1) receptor agonist | Indications: Type 2 diabetes |
References
- Sanofi-Aventis Deutschland GmbH, European Medicines Agency (EMA), [Revised on 18 July 2024] [Accessed on 21 May 2024], Suliqua, INN-insulin glargine+lixisenatide (europa.eu)
- Sanofi-aventis,. US Food and Drug Administration, FDA [Revised on July 2021] [Accessed on 21st May 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208673s013lbl.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Hormones and Hormones Antagonists, 13th edition, 2011, 871 & 877.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.